The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pet Parasite Prevention and Control Drugs Market Research Report 2024
Synopsis
The global Pet Parasite Prevention and Control Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 9%.
This report aims to provide a comprehensive presentation of the global market for Pet Parasite Prevention and Control Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Parasite Prevention and Control Drugs.
Report Scope
The Pet Parasite Prevention and Control Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Parasite Prevention and Control Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Parasite Prevention and Control Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Bayer
Zoetis
Dechra Pharmaceuticals
Chanelle Pharma
Merck Animal Health
Elanco
Virbac
Vetoquinol
Segment by Type
Topical Medication
Injection Medication
Oral Medication
Segment by Application
Dog
Cat
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Parasite Prevention and Control Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Pet Parasite Prevention and Control Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2023 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by year: pet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 9%.
This report aims to provide a comprehensive presentation of the global market for Pet Parasite Prevention and Control Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Parasite Prevention and Control Drugs.
Report Scope
The Pet Parasite Prevention and Control Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pet Parasite Prevention and Control Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pet Parasite Prevention and Control Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Boehringer Ingelheim
Bayer
Zoetis
Dechra Pharmaceuticals
Chanelle Pharma
Merck Animal Health
Elanco
Virbac
Vetoquinol
Segment by Type
Topical Medication
Injection Medication
Oral Medication
Segment by Application
Dog
Cat
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pet Parasite Prevention and Control Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Topical Medication
1.2.3 Injection Medication
1.2.4 Oral Medication
1.3 Market by Application
1.3.1 Global Pet Parasite Prevention and Control Drugs Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Dog
1.3.3 Cat
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pet Parasite Prevention and Control Drugs Market Perspective (2019-2030)
2.2 Pet Parasite Prevention and Control Drugs Growth Trends by Region
2.2.1 Global Pet Parasite Prevention and Control Drugs Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pet Parasite Prevention and Control Drugs Historic Market Size by Region (2019-2024)
2.2.3 Pet Parasite Prevention and Control Drugs Forecasted Market Size by Region (2025-2030)
2.3 Pet Parasite Prevention and Control Drugs Market Dynamics
2.3.1 Pet Parasite Prevention and Control Drugs Industry Trends
2.3.2 Pet Parasite Prevention and Control Drugs Market Drivers
2.3.3 Pet Parasite Prevention and Control Drugs Market Challenges
2.3.4 Pet Parasite Prevention and Control Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pet Parasite Prevention and Control Drugs Players by Revenue
3.1.1 Global Top Pet Parasite Prevention and Control Drugs Players by Revenue (2019-2024)
3.1.2 Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Pet Parasite Prevention and Control Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pet Parasite Prevention and Control Drugs Revenue
3.4 Global Pet Parasite Prevention and Control Drugs Market Concentration Ratio
3.4.1 Global Pet Parasite Prevention and Control Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Parasite Prevention and Control Drugs Revenue in 2023
3.5 Pet Parasite Prevention and Control Drugs Key Players Head office and Area Served
3.6 Key Players Pet Parasite Prevention and Control Drugs Product Solution and Service
3.7 Date of Enter into Pet Parasite Prevention and Control Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Parasite Prevention and Control Drugs Breakdown Data by Type
4.1 Global Pet Parasite Prevention and Control Drugs Historic Market Size by Type (2019-2024)
4.2 Global Pet Parasite Prevention and Control Drugs Forecasted Market Size by Type (2025-2030)
5 Pet Parasite Prevention and Control Drugs Breakdown Data by Application
5.1 Global Pet Parasite Prevention and Control Drugs Historic Market Size by Application (2019-2024)
5.2 Global Pet Parasite Prevention and Control Drugs Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pet Parasite Prevention and Control Drugs Market Size (2019-2030)
6.2 North America Pet Parasite Prevention and Control Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pet Parasite Prevention and Control Drugs Market Size by Country (2019-2024)
6.4 North America Pet Parasite Prevention and Control Drugs Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pet Parasite Prevention and Control Drugs Market Size (2019-2030)
7.2 Europe Pet Parasite Prevention and Control Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pet Parasite Prevention and Control Drugs Market Size by Country (2019-2024)
7.4 Europe Pet Parasite Prevention and Control Drugs Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pet Parasite Prevention and Control Drugs Market Size (2019-2030)
8.2 Asia-Pacific Pet Parasite Prevention and Control Drugs Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pet Parasite Prevention and Control Drugs Market Size by Region (2019-2024)
8.4 Asia-Pacific Pet Parasite Prevention and Control Drugs Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pet Parasite Prevention and Control Drugs Market Size (2019-2030)
9.2 Latin America Pet Parasite Prevention and Control Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pet Parasite Prevention and Control Drugs Market Size by Country (2019-2024)
9.4 Latin America Pet Parasite Prevention and Control Drugs Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pet Parasite Prevention and Control Drugs Market Size (2019-2030)
10.2 Middle East & Africa Pet Parasite Prevention and Control Drugs Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pet Parasite Prevention and Control Drugs Market Size by Country (2019-2024)
10.4 Middle East & Africa Pet Parasite Prevention and Control Drugs Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Detail
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Pet Parasite Prevention and Control Drugs Introduction
11.1.4 Boehringer Ingelheim Revenue in Pet Parasite Prevention and Control Drugs Business (2019-2024)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Bayer
11.2.1 Bayer Company Detail
11.2.2 Bayer Business Overview
11.2.3 Bayer Pet Parasite Prevention and Control Drugs Introduction
11.2.4 Bayer Revenue in Pet Parasite Prevention and Control Drugs Business (2019-2024)
11.2.5 Bayer Recent Development
11.3 Zoetis
11.3.1 Zoetis Company Detail
11.3.2 Zoetis Business Overview
11.3.3 Zoetis Pet Parasite Prevention and Control Drugs Introduction
11.3.4 Zoetis Revenue in Pet Parasite Prevention and Control Drugs Business (2019-2024)
11.3.5 Zoetis Recent Development
11.4 Dechra Pharmaceuticals
11.4.1 Dechra Pharmaceuticals Company Detail
11.4.2 Dechra Pharmaceuticals Business Overview
11.4.3 Dechra Pharmaceuticals Pet Parasite Prevention and Control Drugs Introduction
11.4.4 Dechra Pharmaceuticals Revenue in Pet Parasite Prevention and Control Drugs Business (2019-2024)
11.4.5 Dechra Pharmaceuticals Recent Development
11.5 Chanelle Pharma
11.5.1 Chanelle Pharma Company Detail
11.5.2 Chanelle Pharma Business Overview
11.5.3 Chanelle Pharma Pet Parasite Prevention and Control Drugs Introduction
11.5.4 Chanelle Pharma Revenue in Pet Parasite Prevention and Control Drugs Business (2019-2024)
11.5.5 Chanelle Pharma Recent Development
11.6 Merck Animal Health
11.6.1 Merck Animal Health Company Detail
11.6.2 Merck Animal Health Business Overview
11.6.3 Merck Animal Health Pet Parasite Prevention and Control Drugs Introduction
11.6.4 Merck Animal Health Revenue in Pet Parasite Prevention and Control Drugs Business (2019-2024)
11.6.5 Merck Animal Health Recent Development
11.7 Elanco
11.7.1 Elanco Company Detail
11.7.2 Elanco Business Overview
11.7.3 Elanco Pet Parasite Prevention and Control Drugs Introduction
11.7.4 Elanco Revenue in Pet Parasite Prevention and Control Drugs Business (2019-2024)
11.7.5 Elanco Recent Development
11.8 Virbac
11.8.1 Virbac Company Detail
11.8.2 Virbac Business Overview
11.8.3 Virbac Pet Parasite Prevention and Control Drugs Introduction
11.8.4 Virbac Revenue in Pet Parasite Prevention and Control Drugs Business (2019-2024)
11.8.5 Virbac Recent Development
11.9 Vetoquinol
11.9.1 Vetoquinol Company Detail
11.9.2 Vetoquinol Business Overview
11.9.3 Vetoquinol Pet Parasite Prevention and Control Drugs Introduction
11.9.4 Vetoquinol Revenue in Pet Parasite Prevention and Control Drugs Business (2019-2024)
11.9.5 Vetoquinol Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Topical Medication
Table 3. Key Players of Injection Medication
Table 4. Key Players of Oral Medication
Table 5. Global Pet Parasite Prevention and Control Drugs Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Pet Parasite Prevention and Control Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Pet Parasite Prevention and Control Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Pet Parasite Prevention and Control Drugs Market Share by Region (2019-2024)
Table 9. Global Pet Parasite Prevention and Control Drugs Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Pet Parasite Prevention and Control Drugs Market Share by Region (2025-2030)
Table 11. Pet Parasite Prevention and Control Drugs Market Trends
Table 12. Pet Parasite Prevention and Control Drugs Market Drivers
Table 13. Pet Parasite Prevention and Control Drugs Market Challenges
Table 14. Pet Parasite Prevention and Control Drugs Market Restraints
Table 15. Global Pet Parasite Prevention and Control Drugs Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Pet Parasite Prevention and Control Drugs Market Share by Players (2019-2024)
Table 17. Global Top Pet Parasite Prevention and Control Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Parasite Prevention and Control Drugs as of 2023)
Table 18. Ranking of Global Top Pet Parasite Prevention and Control Drugs Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Pet Parasite Prevention and Control Drugs Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Pet Parasite Prevention and Control Drugs Product Solution and Service
Table 22. Date of Enter into Pet Parasite Prevention and Control Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Pet Parasite Prevention and Control Drugs Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Type (2019-2024)
Table 26. Global Pet Parasite Prevention and Control Drugs Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Type (2025-2030)
Table 28. Global Pet Parasite Prevention and Control Drugs Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Application (2019-2024)
Table 30. Global Pet Parasite Prevention and Control Drugs Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Pet Parasite Prevention and Control Drugs Revenue Market Share by Application (2025-2030)
Table 32. North America Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Pet Parasite Prevention and Control Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Pet Parasite Prevention and Control Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Pet Parasite Prevention and Control Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Pet Parasite Prevention and Control Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Pet Parasite Prevention and Control Drugs Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Pet Parasite Prevention and Control Drugs Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Pet Parasite Prevention and Control Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Pet Parasite Prevention and Control Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Pet Parasite Prevention and Control Drugs Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Pet Parasite Prevention and Control Drugs Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Pet Parasite Prevention and Control Drugs Market Size by Country (2025-2030) & (US$ Million)
Table 47. Boehringer Ingelheim Company Detail
Table 48. Boehringer Ingelheim Business Overview
Table 49. Boehringer Ingelheim Pet Parasite Prevention and Control Drugs Product
Table 50. Boehringer Ingelheim Revenue in Pet Parasite Prevention and Control Drugs Business (2019-2024) & (US$ Million)
Table 51. Boehringer Ingelheim Recent Development
Table 52. Bayer Company Detail
Table 53. Bayer Business Overview
Table 54. Bayer Pet Parasite Prevention and Control Drugs Product
Table 55. Bayer Revenue in Pet Parasite Prevention and Control Drugs Business (2019-2024) & (US$ Million)
Table 56. Bayer Recent Development
Table 57. Zoetis Company Detail
Table 58. Zoetis Business Overview
Table 59. Zoetis Pet Parasite Prevention and Control Drugs Product
Table 60. Zoetis Revenue in Pet Parasite Prevention and Control Drugs Business (2019-2024) & (US$ Million)
Table 61. Zoetis Recent Development
Table 62. Dechra Pharmaceuticals Company Detail
Table 63. Dechra Pharmaceuticals Business Overview
Table 64. Dechra Pharmaceuticals Pet Parasite Prevention and Control Drugs Product
Table 65. Dechra Pharmaceuticals Revenue in Pet Parasite Prevention and Control Drugs Business (2019-2024) & (US$ Million)
Table 66. Dechra Pharmaceuticals Recent Development
Table 67. Chanelle Pharma Company Detail
Table 68. Chanelle Pharma Business Overview
Table 69. Chanelle Pharma Pet Parasite Prevention and Control Drugs Product
Table 70. Chanelle Pharma Revenue in Pet Parasite Prevention and Control Drugs Business (2019-2024) & (US$ Million)
Table 71. Chanelle Pharma Recent Development
Table 72. Merck Animal Health Company Detail
Table 73. Merck Animal Health Business Overview
Table 74. Merck Animal Health Pet Parasite Prevention and Control Drugs Product
Table 75. Merck Animal Health Revenue in Pet Parasite Prevention and Control Drugs Business (2019-2024) & (US$ Million)
Table 76. Merck Animal Health Recent Development
Table 77. Elanco Company Detail
Table 78. Elanco Business Overview
Table 79. Elanco Pet Parasite Prevention and Control Drugs Product
Table 80. Elanco Revenue in Pet Parasite Prevention and Control Drugs Business (2019-2024) & (US$ Million)
Table 81. Elanco Recent Development
Table 82. Virbac Company Detail
Table 83. Virbac Business Overview
Table 84. Virbac Pet Parasite Prevention and Control Drugs Product
Table 85. Virbac Revenue in Pet Parasite Prevention and Control Drugs Business (2019-2024) & (US$ Million)
Table 86. Virbac Recent Development
Table 87. Vetoquinol Company Detail
Table 88. Vetoquinol Business Overview
Table 89. Vetoquinol Pet Parasite Prevention and Control Drugs Product
Table 90. Vetoquinol Revenue in Pet Parasite Prevention and Control Drugs Business (2019-2024) & (US$ Million)
Table 91. Vetoquinol Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pet Parasite Prevention and Control Drugs Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Pet Parasite Prevention and Control Drugs Market Share by Type: 2023 VS 2030
Figure 3. Topical Medication Features
Figure 4. Injection Medication Features
Figure 5. Oral Medication Features
Figure 6. Global Pet Parasite Prevention and Control Drugs Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Pet Parasite Prevention and Control Drugs Market Share by Application: 2023 VS 2030
Figure 8. Dog Case Studies
Figure 9. Cat Case Studies
Figure 10. Others Case Studies
Figure 11. Pet Parasite Prevention and Control Drugs Report Years Considered
Figure 12. Global Pet Parasite Prevention and Control Drugs Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Pet Parasite Prevention and Control Drugs Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Pet Parasite Prevention and Control Drugs Market Share by Region: 2023 VS 2030
Figure 15. Global Pet Parasite Prevention and Control Drugs Market Share by Players in 2023
Figure 16. Global Top Pet Parasite Prevention and Control Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Parasite Prevention and Control Drugs as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Pet Parasite Prevention and Control Drugs Revenue in 2023
Figure 18. North America Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Pet Parasite Prevention and Control Drugs Market Share by Country (2019-2030)
Figure 20. United States Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Pet Parasite Prevention and Control Drugs Market Share by Country (2019-2030)
Figure 24. Germany Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Pet Parasite Prevention and Control Drugs Market Share by Region (2019-2030)
Figure 32. China Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Pet Parasite Prevention and Control Drugs Market Share by Country (2019-2030)
Figure 40. Mexico Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Pet Parasite Prevention and Control Drugs Market Share by Country (2019-2030)
Figure 44. Turkey Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Pet Parasite Prevention and Control Drugs Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Boehringer Ingelheim Revenue Growth Rate in Pet Parasite Prevention and Control Drugs Business (2019-2024)
Figure 47. Bayer Revenue Growth Rate in Pet Parasite Prevention and Control Drugs Business (2019-2024)
Figure 48. Zoetis Revenue Growth Rate in Pet Parasite Prevention and Control Drugs Business (2019-2024)
Figure 49. Dechra Pharmaceuticals Revenue Growth Rate in Pet Parasite Prevention and Control Drugs Business (2019-2024)
Figure 50. Chanelle Pharma Revenue Growth Rate in Pet Parasite Prevention and Control Drugs Business (2019-2024)
Figure 51. Merck Animal Health Revenue Growth Rate in Pet Parasite Prevention and Control Drugs Business (2019-2024)
Figure 52. Elanco Revenue Growth Rate in Pet Parasite Prevention and Control Drugs Business (2019-2024)
Figure 53. Virbac Revenue Growth Rate in Pet Parasite Prevention and Control Drugs Business (2019-2024)
Figure 54. Vetoquinol Revenue Growth Rate in Pet Parasite Prevention and Control Drugs Business (2019-2024)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
